Three Much Talked About Stocks – BAP, CGC And NAN

Three Much Talked About Stocks – BAP, CGC And NAN

Miners, energy and bank stocks are slipping on the ASX, and this was attributed primarily to the negative IMF forecast, after 5-days of an upswing. Among the sectors, consumer staples, health care and discretionary were up, and three stocks from these sectors came under discussion on the ASX. Let’s take a quick look at them. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

BAPCOR LIMITED (ASX: BAP) – Specializing in the sale of Japanese commercial truck spare parts, an acquisition of a group of companies which, the Bapcor anticipates that it will take place shortly. In a combination of the issue of new shares in Bapcor to the value of $9.15M and cash, the purchase price of approximately $61M will be paid to the vendors. For one year from their date of issue the new shares will be subject to voluntary escrow restrictions. The payment of around $15M of the cash consideration amount until one year will be deferred. The company’s stock price is up by 4.209% on acquisition news at $6.190 as at January 23, 2019. The EPS of the stock is 0.339 AUD and slightly high P/E of 17.520.

COSTA GROUP HOLDINGS LIMITED (ASX: CGC) – During December 2018 the company experienced subdued demand in a few categories, namely berry, tomato, and avocado, for a few product lines as well, which has been reflected by this patchy demand. In line with previous guidance which could maintain an annual double digit CAGR for the two calendar years 2017 to 2019, with the expectation that trading for the 2019 calendar year will produce an NPAT-S result. Across the categories, ongoing growth plans continue to track well. The company’s stock price is up by 4.264% at $5.380 as at January 23, 2019, on sectoral gains. The EPS of the stock is 0.360 AUD and the P/E of 14.320 which is decent among its peer basket.

NANOSONICS LIMITED (ASX: NAN) – There is a change in director’s interest for Maurie Stang with some securities held after the change to be 13,879,534 ordinary shares, fully paid and 6,316,983 ordinary shares, fully paid. The globally installed base increased by 25% to 17,740 units, the companies continued to strengthen with a range of new guidelines and studies published internationally. Reflecting the profit of installed base growth, the revenue associated with service and consumables is up by 25% to $35.2 million. With cash balance up to $6.4 million to $69.4 million which supports active growth and expansion. The company’s stock price is up by 3.96% at $3.150 on positive results as at January 23, 2019. The EPS of the stock is 0.019 AUD and the P/E is of 157.410 which is very high.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report